Physician

Oncology

Dr. Antonio C. Buzaid, MD

Dr. Antonio C. Buzaid is an expert in the field of Oncology. Antonio C. Buzaid, MD is a published doctor and has 100 publications published. The lastest was: 'Phase II study of neoadjuvant concurrent biochemotherapy in melanoma patients with local-regional metastases.'

Publications

Cutaneous melanoma in Latin America: the need for more data.
Identifying important breast cancer control strategies in Asia, Latin America and the Middle East/North Africa.
High-dose interleukin-2 in patients with metastatic melanoma whose disease progressed after biochemotherapy.
Cetuximab Plus irinotecan in pretreated metastatic colorectal cancer progressing on irinotecan: the LABEL study.
Impact of F-18 FDG-PET/CT in the restaging and management of patients with malignant melanoma.
Breast cancer in Latin America: experts perceptions compared with medical care standards.
Final version of 2009 AJCC melanoma staging and classification.
Staging of cutaneous melanoma.
Peritonectomy for peritoneal carcinomatosis: long-term outcomes from a single Brazilian institution.
A randomized phase III trial of biochemotherapy versus interferon-alpha-2b for adjuvant therapy in patients at high risk for melanoma recurrence.
Exploring the role of novel agents in the treatment of renal cell carcinoma.
Breast cancer in Latin America: results of the Latin American and Caribbean Society of Medical Oncology/Breast Cancer Research Foundation expert survey.
Electrochemical therapy to treat cancer (in vivo treatment).
Dendritic cells derived from metastatic cancer patients vaccinated with allogeneic dendritic cell-autologous tumor cell hybrids express more CD86 and induce higher lev...
Dendritic cell-tumor cell hybrid vaccination for metastatic cancer.
Management of metastatic cutaneous melanoma.
Temozolomide for the treatment of brain metastases associated with metastatic melanoma: a phase II study.
An evidence-based staging system for cutaneous melanoma.
New TNM melanoma staging system: linking biology and natural history to clinical outcomes.
Acinar cell carcinoma of the pancreas.
Biochemotherapy for advanced melanoma.
Phase I trial of subcutaneous recombinant human interleukin-2 in patients with metastatic melanoma.
Association of carmustine with a lipid emulsion: in vitro, in vivo and preliminary studies in cancer patients.
Sequential biochemotherapy versus chemotherapy for metastatic melanoma: results from a phase III randomized trial.
Practical guidelines for the management of biochemotherapy-related toxicity in melanoma.
Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma.
Inducible nitric oxide synthase and nitrotyrosine in human metastatic melanoma tumors correlate with poor survival.
Classification and staging of melanoma.
Unexpected cytokines in serum of malignant melanoma patients during sequential biochemotherapy.
Clinical classification and staging.
The changing prognosis of melanoma.
Strategies for combining chemotherapy and biotherapy in melanoma.
A phase II study of "decrescendo" interleukin-2 plus interferon-alpha-2a in patients with progressive metastatic melanoma after chemotherapy.
A new American Joint Committee on Cancer staging system for cutaneous melanoma.
Follow-up recommendations for patients with American Joint Committee on Cancer Stages I-III malignant melanoma.
Pilot study of intra-arterial cisplatin and intravenous vinblastine and dacarbazine in patients with melanoma in-transit metastases.
Phase II trial of escalated dose of tirapazamine combined with cisplatin in advanced malignant melanoma.
Phase II trial of doxil for patients with metastatic melanoma refractory to frontline therapy.
Differential increase of Fas ligand expression on metastatic and thin or thick primary melanoma cells compared with interleukin-10.
Phase II study of neoadjuvant concurrent biochemotherapy in melanoma patients with local-regional metastases.
Enhancement of cell-mediated immunity in melanoma patients immunized with murine anti-idiotypic monoclonal antibodies (MELIMMUNE) that mimic the high molecular weight ...
NCCN melanoma practice guidelines. National Comprehensive Cancer Network.
Development of a biochemotherapy regimen with concurrent administration of cisplatin, vinblastine, dacarbazine, interferon alfa, and interleukin-2 for patients with me...
Melanin content and downregulation of glutathione S-transferase contribute to the action of L-buthionine-S-sulfoximine on human melanoma.
DNA damage in peripheral blood mononuclear cells correlates with response to biochemotherapy in melanoma.
Nitric oxide and neopterin levels and clinical response in stage III melanoma patients receiving concurrent biochemotherapy.
Prognostic factors for survival of patients treated systemically for disseminated melanoma.
Active immunotherapy with ultraviolet B-irradiated autologous whole melanoma cells plus DETOX in patients with metastatic melanoma.
A prospective crossover randomized trial of novobiocin and rifampin prophylaxis for the prevention of intravascular catheter infections in cancer patients treated with...
Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections. A randomized, double-blin...
Evaluation of tyrosinase mRNA as a tumor marker in the blood of melanoma patients.
Selective and synergistic activity of L-S,R-buthionine sulfoximine on malignant melanoma is accompanied by decreased expression of glutathione-S-transferase.
Minocycline and ethylenediaminetetraacetate for the prevention of recurrent vascular catheter infections.
A phase II study of interferon-alpha 2b with dacarbazine, carmustine, cisplatin and tamoxifen in metastatic melanoma.
Phase II trial of tirapazamine combined with cisplatin in chemotherapy of advanced malignant melanoma.
Critical analysis of the current American Joint Committee on Cancer staging system for cutaneous melanoma and proposal of a new staging system.
Treatment of advanced pancreatic adenocarcinoma with 5-FU, leucovorin, interferon-alpha-2b, and cisplatin.
Treatment of metastatic melanoma with combined chemotherapy containing cisplatin, vinblastine and dacarbazine (CVD) and biotherapy using interleukin-2 and interferon-a...
Interleukin-6 production and secretion in human melanoma cell lines: regulation by interleukin-1.
Polymerase chain reaction for detection of melanoma in peripheral blood: too early to assess clinical value.
Phase Ia/Ib trial of anti-GD2 chimeric monoclonal antibody 14.18 (ch14.18) and recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) in metasta...
Finally, a successful adjuvant therapy for high-risk melanoma.
Trifluoperazine as a modulator of multidrug resistance in refractory breast cancer.
Detection of melanoma cells in peripheral blood using reverse transcription polymerase chain reaction assay for tyrosinase mRNA.
Interaction of chemotherapy and biological response modifiers in the treatment of melanoma.
Phase II trial of docetaxel in patients with advanced cutaneous malignant melanoma previously untreated with chemotherapy.
Systemic treatments for advanced cutaneous melanoma.
Multiple primary melanomas: data and significance.
Prognostic value of size of lymph node metastases in patients with cutaneous melanoma.
Acute rhabdomyolysis after concurrent administration of interleukin-2, interferon-alfa, and chemotherapy for metastatic melanoma.
Role of computed tomography in the staging of patients with local-regional metastases of melanoma.
Biochemical modulation of 5-fluorouracil with brequinar: results of a phase I study.
Combination of chemotherapy with interleukin-2 and interferon-alfa for the treatment of advanced melanoma.
Pilot study of preoperative chemotherapy with cisplatin, vinblastine, and dacarbazine in patients with local-regional recurrence of melanoma.
Neuron-specific enolase as a tumor marker in metastatic melanoma.
Correlation between lipid-associated sialic acid and tumor burden in melanoma.
Mechanism of the anti-tumour effect of biochemotherapy in melanoma: preliminary results.
Cisplatin, doxorubicin, mitomycin C, and 5-fluorouracil for the treatment of metastatic non-small cell lung cancer. Limited activity of an aggressive chemotherapy regi...
Role of recombinant interleukin-2 in combination with interferon-alfa and chemotherapy in the treatment of advanced melanoma.
Role of computed tomography in the staging of primary melanoma.
Chemotherapy and radiation for the treatment of non-small-cell lung cancer. A critical review.
A phase II trial of mitomycin C, 5-fluorouracil and radiation therapy in the treatment of unresectable non-small cell lung cancer.
Giant cell carcinoma of the lung.
Lung cancer: a review of current therapeutic modalities.
Chemotherapy for advanced malignant melanoma.
High-dose cisplatin with dacarbazine and tamoxifen in the treatment of metastatic melanoma.
High-dose cisplatin plus WR-2721 in a split course in metastatic malignant melanoma. A phase II study.
Critical analysis of neoadjuvant therapy for Stage IIIa non-small cell lung cancer corrected.
The role of interferons in the treatment of malignant neoplasms.
Therapeutic options in renal cell carcinoma.
Managing malignant pericardial effusion.
Effect of dipyridamole on fluorodeoxyuridine cytotoxicity in vitro and in cancer patients.
Phase II trial of fenretinide N-(4-hydroxyphenyl) retinamide in myelodysplasia: possible retinoid-induced disease acceleration.
Management of refractory myeloma: a review.
Danazol in the treatment of myelodysplastic syndromes.
Salvage therapy of advanced Hodgkin's disease. Critical appraisal of curative potential.
Phase II study of interferon alfa-2a, recombinant (Roferon-A) in metastatic renal cell carcinoma.
Cranial metastases from prostate cancer simulating meningioma: report of two cases and review of the literature.
13-cis-retinoic acid in myelodysplastic syndromes.

Doctors Specialties

Medical Oncology
Oncology

Accepted Insurances

Helpful Reviews

Give Anonymous Review

Similar Doctors

	Dr. Paul B. Koller, MD This Doctor is OpenDoctor Recommended.
	Dr. Robert S. Benjamin, MD
	Dr. Jeri Kim, MD This Doctor is OpenDoctor Recommended.
	Dr. Banu K. Arun, MD This Doctor is OpenDoctor Recommended.
	Dr. Rajul Jain, MD
	Dr. Pierre Saintigny, MD This Doctor is OpenDoctor Recommended.
	Dr. Tejal A. Patel, MD This Doctor is OpenDoctor Recommended.